Alicia Rossi

834 total citations
16 papers, 652 citations indexed

About

Alicia Rossi is a scholar working on Molecular Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Alicia Rossi has authored 16 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Medicine, 6 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in Alicia Rossi's work include Antibiotic Resistance in Bacteria (8 papers), Pneumonia and Respiratory Infections (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Alicia Rossi is often cited by papers focused on Antibiotic Resistance in Bacteria (8 papers), Pneumonia and Respiratory Infections (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Alicia Rossi collaborates with scholars based in Argentina, United States and Brazil. Alicia Rossi's co-authors include Alejandra Corso, José Luis Di Fábio, Marcelo Galas, Rosario Palacio, María Hortal, Raúl Ruvinsky, Alejandro Petroni, Roberto G. Melano, Ilda Santos‐Sanches and Marta Aires-de-Sousa and has published in prestigious journals such as PEDIATRICS, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Alicia Rossi

16 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alicia Rossi Argentina 13 294 226 195 147 140 16 652
P Urbášková Czechia 15 346 1.2× 185 0.8× 244 1.3× 122 0.8× 84 0.6× 44 662
Anan Chongthaleong Thailand 11 332 1.1× 206 0.9× 213 1.1× 65 0.4× 111 0.8× 17 690
Jiso Ryu South Korea 10 264 0.9× 312 1.4× 152 0.8× 55 0.4× 101 0.7× 20 608
Jui‐Fen Lai Taiwan 19 277 0.9× 406 1.8× 310 1.6× 213 1.4× 152 1.1× 28 920
Rohani Md Yasin Malaysia 12 481 1.6× 429 1.9× 155 0.8× 134 0.9× 220 1.6× 18 962
Jennifer Coetzee South Africa 10 165 0.6× 383 1.7× 164 0.8× 75 0.5× 167 1.2× 23 659
Janusz Fiett Poland 15 180 0.6× 502 2.2× 108 0.6× 156 1.1× 264 1.9× 18 679
Guilène Barnaud France 14 244 0.8× 584 2.6× 240 1.2× 298 2.0× 277 2.0× 23 1.1k
G. Laurans France 14 250 0.9× 302 1.3× 164 0.8× 70 0.5× 189 1.4× 46 608
Wen-Hwei Chen Taiwan 6 170 0.6× 373 1.7× 129 0.7× 115 0.8× 117 0.8× 7 670

Countries citing papers authored by Alicia Rossi

Since Specialization
Citations

This map shows the geographic impact of Alicia Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicia Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicia Rossi more than expected).

Fields of papers citing papers by Alicia Rossi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alicia Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicia Rossi. The network helps show where Alicia Rossi may publish in the future.

Co-authorship network of co-authors of Alicia Rossi

This figure shows the co-authorship network connecting the top 25 collaborators of Alicia Rossi. A scholar is included among the top collaborators of Alicia Rossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicia Rossi. Alicia Rossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Petroni, Alejandro, Roberto G. Melano, Héctor A. Saka, et al.. (2004). CARB-9, a Carbenicillinase Encoded in the VCR Region of Vibrio cholerae Non-O1, Non-O139 Belongs to a Family of Cassette-Encoded β-Lactamases. Antimicrobial Agents and Chemotherapy. 48(10). 4042–4046. 33 indexed citations
2.
Petroni, Alejandro, et al.. (2002). Plasmidic Extended-Spectrum β-Lactamases in Vibrio cholerae O1 El Tor Isolates in Argentina. Antimicrobial Agents and Chemotherapy. 46(5). 1462–1468. 73 indexed citations
3.
Melano, Roberto G., Alejandro Petroni, Héctor A. Saka, et al.. (2002). New Carbenicillin-Hydrolyzing β-Lactamase (CARB-7) from Vibrio cholerae Non-O1, Non-O139 Strains Encoded by the VCR Region of the V. cholerae Genome. Antimicrobial Agents and Chemotherapy. 46(7). 2162–2168. 38 indexed citations
4.
Aires-de-Sousa, Marta, Maria Miragaia, Ilda Santos‐Sanches, et al.. (2001). Three-Year Assessment of Methicillin-Resistant Staphylococcus aureus Clones in Latin America from 1996 to 1998. Journal of Clinical Microbiology. 39(6). 2197–2205. 83 indexed citations
5.
Hortal, María, Raúl Ruvinsky, Alicia Rossi, et al.. (2000). Impacto de Streptococcus pneumoniae en las neumonías del niño latinoamericano. Revista Panamericana de Salud Pública. 8(3). 185–195. 18 indexed citations
6.
Rossi, Alicia, et al.. (1999). ACTIVIDAD IN VITRO DE TROVAFLOXACINA, OTRAS FLUOROQUINOLONAS Y DE DIFERENTES ANTIMICROBIANOS FRENTE A AISLAMIENTOS CLINICOS. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 59. 8–16. 4 indexed citations
7.
Lovgren, Marguerite, Rosario Palacio, Gabriela Echániz-Avilés, et al.. (1999). Determination of Trimethoprim-Sulfamethoxazole Resistance in Streptococcus pneumoniae by Using the E Test with Mueller-Hinton Agar Supplemented with Sheep or Horse Blood May Be Unreliable. Journal of Clinical Microbiology. 37(1). 215–217. 12 indexed citations
8.
Rossi, Alicia, et al.. (1999). Vigilancia de la resistencia a los antibacterianos en Argentina. Programa WHONET, 1995-1996. Revista Panamericana de Salud Pública. 6(4). 234–242. 22 indexed citations
9.
Bantar, Carlos, et al.. (1999). Pharmacokinetics and Pharmacodynamics of Amoxicillin-Sulbactam, a Novel Aminopenicillin–β-Lactamase Inhibitor Combination, against Escherichia coli. Antimicrobial Agents and Chemotherapy. 43(6). 1503–1504. 11 indexed citations
10.
Deeks, Shelley L., Rosario Palacio, Raúl Ruvinsky, et al.. (1999). Risk Factors and Course of Illness Among Children With Invasive Penicillin-resistant Streptococcus pneumoniae. PEDIATRICS. 103(2). 409–413. 119 indexed citations
11.
Tomasz, Alexander, Alejandra Corso, Elena Severina, et al.. (1998). Molecular Epidemiologic Characterization of Penicillin-Resistant Streptococcus pneumoniae Invasive Pediatric Isolates Recovered in Six Latin-American Countries: An Overview. Microbial Drug Resistance. 4(3). 195–207. 67 indexed citations
12.
Santos‐Sanches, Ilda, et al.. (1998). Spread of a Methicillin-Resistant and Multiresistant Epidemic Clone of Staphylococcus aureus in Argentina. Microbial Drug Resistance. 4(4). 277–288. 49 indexed citations
13.
Rossi, Alicia, et al.. (1998). Penicillin-Resistant Streptococcus pneumoniae in Argentina: Frequent Occurrence of an Internationally Spread Serotype 14 Clone. Microbial Drug Resistance. 4(3). 225–231. 25 indexed citations
14.
Rossi, Alicia, Raúl Ruvinsky, Mabel Regueira, et al.. (1997). Distribution of Capsular Types and Penicillin-Resistance of Strains of Streptococcus pneumoniae Causing Systemic Infections in Argentinian Children Under 5 Years of Age. Microbial Drug Resistance. 3(2). 135–140. 34 indexed citations
15.
Rossi, Alicia, et al.. (1995). Non-typhoid Salmonella spp. resistant to cefotaxime. Journal of Antimicrobial Chemotherapy. 36(4). 697–702. 39 indexed citations
16.
Pagani, Laura, et al.. (1994). Outbreak of extended-spectrum β-lactamase producingSerratia marcescensin an intensive care unit. FEMS Immunology & Medical Microbiology. 10(1). 39–46. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026